Global Medical Aesthetics Market 2023
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
The global medical aesthetics market is experiencing rapid growth, with a projected compound annual growth rate (CAGR) of 10.2% from 2023 to 2029. This growth is expected to propel the market to reach a value of USD 47.43 billion by 2029, a significant increase from USD 23.46 billion in 2022. Several key trends are driving this growth in the industry.
One of the primary factors contributing to the expansion of the medical aesthetics market is the increasing number of younger consumers seeking aesthetic procedures. This demographic is becoming more conscious of their appearance and is actively seeking ways to enhance their physical features. Additionally, there has been a notable rise in the number of men seeking cosmetic enhancements, further fueling the demand for medical aesthetics procedures.
Another trend shaping the market is the preference for non-invasive options. Patients are increasingly opting for procedures that do not require surgery or extensive downtime. This preference is driven by the desire for quicker recovery times and minimal scarring. The availability of advanced devices and products from both global and local vendors has made non-invasive options more accessible and appealing to consumers.
In terms of specific procedures, popular choices in the medical aesthetics market include facelifts, liposuction, botox injections, skin resurfacing, and intense pulse light (IPL) treatments. These procedures are designed to improve the appearance of individuals through minimally invasive or non-invasive techniques. For example, facelifts can help reduce the signs of aging, while liposuction targets unwanted fat deposits. Botox injections are commonly used to reduce wrinkles, and skin resurfacing procedures aim to improve the texture and tone of the skin. IPL treatments are effective for various skin issues, such as pigmentation and vascular lesions.
Despite the challenges posed by the COVID-19 pandemic, the demand for cosmetic treatments has seen a 3% increase. This indicates the resilience of the medical aesthetics market and the continued interest of individuals in enhancing their appearance. One popular injectable treatment is platelet-rich plasma (PRP), which utilizes the patients own blood cells to rejuvenate the skin. Laser applications are also widely used for various skin concerns, further contributing to the growth of the market.
Affordability and minimal risk are key factors driving the preference for non-invasive procedures. These treatments offer a more cost-effective option compared to surgical interventions and carry fewer risks and complications. As a result, non-invasive procedures have gained popularity among a wide range of individuals, including both younger and aging populations.
Furthermore, the growth of the medical aesthetics market is also influenced by medical tourism, often referred to as aesthetic medicine tourism. Patients are increasingly traveling to different countries to access high-quality and cost-effective medical aesthetics treatments. This trend has contributed to the expansion of the market on a global scale.
Market Segmentation
The global liquid handling systems market can be analyzed through several important segments that provide insights into the key products, applications, end-users, and regions that comprise this industry:
By Procedure
Minimally Invasive Procedure
Non-Invasive Procedure
By Product
Body Contouring Devices
Cosmetic Implants
Filler and Neuromodulators
Laser and Energy-Based Devices
Microdermabrasion (MDA)
Microneedling and Chemical Peels
Others
By Application
Body Contouring and Cellulite Reduction
Breast Augmentation
Facial Aesthetics
Skin Tightening and Brightening
Others
By End User
Homecare
Hospital and Skin Clinics
Medical Spa
By Geography
North America US, Canada
Europe Germany, France, UK, Italy, Spain
APAC - China, Japan, India, South Korea, Australia
Latin America Brazil, Mexico, Argentina
Middle East & Africa South Africa, Saudi Arabia, Turkey
The medical aesthetics market comprises non-invasive and minimally invasive procedures focused on improving cosmetic appearance and enhancing patient satisfaction.
In 2022, minimally invasive procedures represented over half of the total market, holding a 57.3% share. These procedures involve minor skin breaching using specialized devices and include treatments like laser resurfacing, injectables, and minor liposuction. Their minimal surgical intervention coupled with benefits such as shorter recovery periods, reduced pain/discomfort, and higher safety profiles are driving adoption.
The remaining 42.5% share was accounted for by completely non-invasive procedures like skin tightening, body contouring, and cellulite reduction which are performed externally on the skins surface. These are gaining popularity due to the absence of surgical risks, with technologies like laser and ultrasound providing visible improvements safely and effectively.
Medical aesthetics market is further segmented by product: body contouring devices, cosmetic implants, filler and neuromodulators, laser and energy-based devices, microdermabrasion (MDA), microneedling and chemical peels, others.
Body contouring devices represent the largest product segment in the medical aesthetics market, commanding a 27.1% market share. This segment comprises minimally invasive devices for fat reduction and body sculpting, including systems like non-invasive laser lipolysis, cryolipolysis, radiofrequency and ultrasound.
The high demand for body contouring procedures is fueled by their ability to reduce localized fat deposits and improve body shape and tone with minimal discomfort or downtime. Patients are increasingly seeking these procedures as an alternative to more invasive surgical options like liposuction. The convenience, safety profile and visible, longer-lasting results delivered by body contouring treatments are key growth drivers.
Following closely behind are laser and energy-based devices, holding a 21.7% market share. This segment covers aesthetic skin treatment systems utilizing laser, radiofrequency and intense pulsed light. These devices enable procedures like skin rejuvenation, tightening, hair removal and vascular lesion removal. Their versatility and technological improvements support continual adoption for both facial and body treatments.
Other product segments each account for smaller yet substantial market shares. Cosmetic implants comprise both facial and breast augmentation implants. Dermal fillers and neuromodulators include injectable anti-wrinkle solutions. Micro-needling and chemical peels are minimally invasive skin revitalization techniques. Microdermabrasion is a mild skin exfoliation method.
The key application segments in the market are body contouring and cellulite reduction, skin tightening and resurfacing, facial aesthetics, breast augmentation, and others. Body contouring and cellulite reduction hold the largest share at 30.8%, driven by the demand for fat reduction and liposuction procedures. Skin tightening and resurfacing procedures are also gaining popularity.
Hospitals and skin clinics are the primary end-users, accounting for 55.0% of the market in 2022. The increasing demand for minimally invasive and non-invasive procedures drives patients to seek treatment in these settings. North America is the largest market, with the United States contributing significantly to industry growth. The Asia-Pacific region is expected to witness faster growth, driven by factors such as an aging population, increased acceptance of cosmetic surgeries, and higher expenditure on medical aesthetic procedures. Countries like Japan, China, India, South Korea, and Australia offer promising market growth opportunities.
Competitive Landscape
The global medical aesthetics market is highly competitive, with numerous vendors offering a wide range of products and treatments. Prominent industry players like Abbvie Inc. (Allergan plc), Sisram Medical Ltd., Cutera Inc., Lumenis Inc., Bausch & Lomb Incorporated, and El. En. S.p.A. have a strong presence. This report profiles key companies including Abbvie Inc. (Allergan plc), Aerolase Corporation, Aesthetics Biomedical, Inc., Asclepion Laser Technologies GmbH, Astanza Laser LLC, Bausch & Lomb Incorporated, Bausch Health Companies Inc., Beijing Sanhe Beauty S & T Co., Ltd., biolitec AG, Biotec Italia Srl, Brera Medical Technologies Srl, Candela Corporation, Cartessa Aesthetics, LLC, Celling Biosciences, LLC. (ThermiGen), Cutera Inc., Cynosure, LLC, Dominion Aesthetic Technologies, Inc., El. En. S.p.A., Endymed Ltd., Erchonia Corporation, Galderma S.A., Inmode Ltd, Johnson & Johnson, Linline Medical Systems, SIA, Lumenis Inc., Lutronic, Inc., Lynton Lasers Ltd, MedArt ApS, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Meyer-Haake GmbH, Microaire Surgical Instruments LLC, Revance Therapeutics, Inc., Sciton, Inc., Sientra, Inc., Sisram Medical Ltd., Venus Concept Inc., WAVEMED SRL, Wuhan Gigaa Optronics Technology Co., Ltd., Zimmer MedizinSysteme GmbH, among others.
Scope of the Report
To analyze and forecast the market size of the global medical aesthetics market.
To classify and forecast the global medical aesthetics market based on procedure, product, application, end user, geography.
To identify drivers and challenges for the global medical aesthetics market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global medical aesthetics market.
To identify and analyze the profile of leading players operating in the global medical aesthetics market.
Why Choose This Report
Gain a reliable outlook of the global medical aesthetics market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Companies Mentioned
Abbvie Inc. (Allergan plc), Aerolase Corporation, Aesthetics Biomedical Inc., Asclepion Laser Technologies GmbH, Astanza Laser LLC, Bausch & Lomb Incorporated, Bausch Health Companies Inc., Beijing Sanhe Beauty S & T Co. Ltd., biolitec AG, Biotec Italia Srl, Brera Medical Technologies Srl, Candela Corporation, Cartessa Aesthetics LLC, Celling Biosciences LLC. (ThermiGen), Cutera Inc., Cynosure LLC, Dominion Aesthetic Technologies Inc., El. En. S.p.A., Endymed Ltd., Erchonia Corporation, Galderma S.A., Inmode Ltd, Johnson & Johnson, Linline Medical Systems SIA, Lumenis Inc., Lutronic Inc., Lynton Lasers Ltd, MedArt ApS, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Meyer-Haake GmbH, Microaire Surgical Instruments LLC, Revance Therapeutics Inc., Sciton Inc., Sientra Inc., Sisram Medical Ltd., Venus Concept Inc., WAVEMED SRL, Wuhan Gigaa Optronics Technology Co. Ltd., Zimmer MedizinSysteme GmbH
One of the primary factors contributing to the expansion of the medical aesthetics market is the increasing number of younger consumers seeking aesthetic procedures. This demographic is becoming more conscious of their appearance and is actively seeking ways to enhance their physical features. Additionally, there has been a notable rise in the number of men seeking cosmetic enhancements, further fueling the demand for medical aesthetics procedures.
Another trend shaping the market is the preference for non-invasive options. Patients are increasingly opting for procedures that do not require surgery or extensive downtime. This preference is driven by the desire for quicker recovery times and minimal scarring. The availability of advanced devices and products from both global and local vendors has made non-invasive options more accessible and appealing to consumers.
In terms of specific procedures, popular choices in the medical aesthetics market include facelifts, liposuction, botox injections, skin resurfacing, and intense pulse light (IPL) treatments. These procedures are designed to improve the appearance of individuals through minimally invasive or non-invasive techniques. For example, facelifts can help reduce the signs of aging, while liposuction targets unwanted fat deposits. Botox injections are commonly used to reduce wrinkles, and skin resurfacing procedures aim to improve the texture and tone of the skin. IPL treatments are effective for various skin issues, such as pigmentation and vascular lesions.
Despite the challenges posed by the COVID-19 pandemic, the demand for cosmetic treatments has seen a 3% increase. This indicates the resilience of the medical aesthetics market and the continued interest of individuals in enhancing their appearance. One popular injectable treatment is platelet-rich plasma (PRP), which utilizes the patients own blood cells to rejuvenate the skin. Laser applications are also widely used for various skin concerns, further contributing to the growth of the market.
Affordability and minimal risk are key factors driving the preference for non-invasive procedures. These treatments offer a more cost-effective option compared to surgical interventions and carry fewer risks and complications. As a result, non-invasive procedures have gained popularity among a wide range of individuals, including both younger and aging populations.
Furthermore, the growth of the medical aesthetics market is also influenced by medical tourism, often referred to as aesthetic medicine tourism. Patients are increasingly traveling to different countries to access high-quality and cost-effective medical aesthetics treatments. This trend has contributed to the expansion of the market on a global scale.
Market Segmentation
The global liquid handling systems market can be analyzed through several important segments that provide insights into the key products, applications, end-users, and regions that comprise this industry:
By Procedure
Minimally Invasive Procedure
Non-Invasive Procedure
By Product
Body Contouring Devices
Cosmetic Implants
Filler and Neuromodulators
Laser and Energy-Based Devices
Microdermabrasion (MDA)
Microneedling and Chemical Peels
Others
By Application
Body Contouring and Cellulite Reduction
Breast Augmentation
Facial Aesthetics
Skin Tightening and Brightening
Others
By End User
Homecare
Hospital and Skin Clinics
Medical Spa
By Geography
North America US, Canada
Europe Germany, France, UK, Italy, Spain
APAC - China, Japan, India, South Korea, Australia
Latin America Brazil, Mexico, Argentina
Middle East & Africa South Africa, Saudi Arabia, Turkey
The medical aesthetics market comprises non-invasive and minimally invasive procedures focused on improving cosmetic appearance and enhancing patient satisfaction.
In 2022, minimally invasive procedures represented over half of the total market, holding a 57.3% share. These procedures involve minor skin breaching using specialized devices and include treatments like laser resurfacing, injectables, and minor liposuction. Their minimal surgical intervention coupled with benefits such as shorter recovery periods, reduced pain/discomfort, and higher safety profiles are driving adoption.
The remaining 42.5% share was accounted for by completely non-invasive procedures like skin tightening, body contouring, and cellulite reduction which are performed externally on the skins surface. These are gaining popularity due to the absence of surgical risks, with technologies like laser and ultrasound providing visible improvements safely and effectively.
Medical aesthetics market is further segmented by product: body contouring devices, cosmetic implants, filler and neuromodulators, laser and energy-based devices, microdermabrasion (MDA), microneedling and chemical peels, others.
Body contouring devices represent the largest product segment in the medical aesthetics market, commanding a 27.1% market share. This segment comprises minimally invasive devices for fat reduction and body sculpting, including systems like non-invasive laser lipolysis, cryolipolysis, radiofrequency and ultrasound.
The high demand for body contouring procedures is fueled by their ability to reduce localized fat deposits and improve body shape and tone with minimal discomfort or downtime. Patients are increasingly seeking these procedures as an alternative to more invasive surgical options like liposuction. The convenience, safety profile and visible, longer-lasting results delivered by body contouring treatments are key growth drivers.
Following closely behind are laser and energy-based devices, holding a 21.7% market share. This segment covers aesthetic skin treatment systems utilizing laser, radiofrequency and intense pulsed light. These devices enable procedures like skin rejuvenation, tightening, hair removal and vascular lesion removal. Their versatility and technological improvements support continual adoption for both facial and body treatments.
Other product segments each account for smaller yet substantial market shares. Cosmetic implants comprise both facial and breast augmentation implants. Dermal fillers and neuromodulators include injectable anti-wrinkle solutions. Micro-needling and chemical peels are minimally invasive skin revitalization techniques. Microdermabrasion is a mild skin exfoliation method.
The key application segments in the market are body contouring and cellulite reduction, skin tightening and resurfacing, facial aesthetics, breast augmentation, and others. Body contouring and cellulite reduction hold the largest share at 30.8%, driven by the demand for fat reduction and liposuction procedures. Skin tightening and resurfacing procedures are also gaining popularity.
Hospitals and skin clinics are the primary end-users, accounting for 55.0% of the market in 2022. The increasing demand for minimally invasive and non-invasive procedures drives patients to seek treatment in these settings. North America is the largest market, with the United States contributing significantly to industry growth. The Asia-Pacific region is expected to witness faster growth, driven by factors such as an aging population, increased acceptance of cosmetic surgeries, and higher expenditure on medical aesthetic procedures. Countries like Japan, China, India, South Korea, and Australia offer promising market growth opportunities.
Competitive Landscape
The global medical aesthetics market is highly competitive, with numerous vendors offering a wide range of products and treatments. Prominent industry players like Abbvie Inc. (Allergan plc), Sisram Medical Ltd., Cutera Inc., Lumenis Inc., Bausch & Lomb Incorporated, and El. En. S.p.A. have a strong presence. This report profiles key companies including Abbvie Inc. (Allergan plc), Aerolase Corporation, Aesthetics Biomedical, Inc., Asclepion Laser Technologies GmbH, Astanza Laser LLC, Bausch & Lomb Incorporated, Bausch Health Companies Inc., Beijing Sanhe Beauty S & T Co., Ltd., biolitec AG, Biotec Italia Srl, Brera Medical Technologies Srl, Candela Corporation, Cartessa Aesthetics, LLC, Celling Biosciences, LLC. (ThermiGen), Cutera Inc., Cynosure, LLC, Dominion Aesthetic Technologies, Inc., El. En. S.p.A., Endymed Ltd., Erchonia Corporation, Galderma S.A., Inmode Ltd, Johnson & Johnson, Linline Medical Systems, SIA, Lumenis Inc., Lutronic, Inc., Lynton Lasers Ltd, MedArt ApS, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Meyer-Haake GmbH, Microaire Surgical Instruments LLC, Revance Therapeutics, Inc., Sciton, Inc., Sientra, Inc., Sisram Medical Ltd., Venus Concept Inc., WAVEMED SRL, Wuhan Gigaa Optronics Technology Co., Ltd., Zimmer MedizinSysteme GmbH, among others.
Scope of the Report
To analyze and forecast the market size of the global medical aesthetics market.
To classify and forecast the global medical aesthetics market based on procedure, product, application, end user, geography.
To identify drivers and challenges for the global medical aesthetics market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global medical aesthetics market.
To identify and analyze the profile of leading players operating in the global medical aesthetics market.
Why Choose This Report
Gain a reliable outlook of the global medical aesthetics market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Companies Mentioned
Abbvie Inc. (Allergan plc), Aerolase Corporation, Aesthetics Biomedical Inc., Asclepion Laser Technologies GmbH, Astanza Laser LLC, Bausch & Lomb Incorporated, Bausch Health Companies Inc., Beijing Sanhe Beauty S & T Co. Ltd., biolitec AG, Biotec Italia Srl, Brera Medical Technologies Srl, Candela Corporation, Cartessa Aesthetics LLC, Celling Biosciences LLC. (ThermiGen), Cutera Inc., Cynosure LLC, Dominion Aesthetic Technologies Inc., El. En. S.p.A., Endymed Ltd., Erchonia Corporation, Galderma S.A., Inmode Ltd, Johnson & Johnson, Linline Medical Systems SIA, Lumenis Inc., Lutronic Inc., Lynton Lasers Ltd, MedArt ApS, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Meyer-Haake GmbH, Microaire Surgical Instruments LLC, Revance Therapeutics Inc., Sciton Inc., Sientra Inc., Sisram Medical Ltd., Venus Concept Inc., WAVEMED SRL, Wuhan Gigaa Optronics Technology Co. Ltd., Zimmer MedizinSysteme GmbH
TABLE OF CONTENTS
PART 1. INTRODUCTION
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL MEDICAL AESTHETICS MARKET BY PROCEDURE
5.1 Minimally invasive procedure
5.2 Non-invasive procedure
PART 6. GLOBAL MEDICAL AESTHETICS MARKET BY PRODUCT
6.1 Body contouring devices
6.2 Cosmetic implants
6.3 Filler and neuromodulators
6.4 Laser and energy-based devices
6.5 Microdermabrasion (MDA)
6.6 Microneedling and chemical peels
6.7 Others
PART 7. GLOBAL MEDICAL AESTHETICS MARKET BY APPLICATION
7.1 Body contouring and cellulite reduction
7.2 Breast augmentation
7.3 Facial aesthetics
7.4 Skin tightening and brightening
7.5 Others
PART 8. GLOBAL MEDICAL AESTHETICS MARKET BY END USER
8.1 Homecare
8.2 Hospital and skin clinics
8.3 Medical spa
PART 9. GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY
9.1 North America
9.2 Europe
9.3 APAC
9.4 Latin America
9.5 Middle East & Africa
PART 10. COMPANY PROFILES
10.1 Abbvie Inc. (Allergan plc)
10.2 Aerolase Corporation
10.3 Aesthetics Biomedical, Inc.
10.4 Asclepion Laser Technologies GmbH
10.5 Astanza Laser LLC
10.6 Bausch & Lomb Incorporated
10.7 Bausch Health Companies Inc.
10.8 Beijing Sanhe Beauty S & T Co., Ltd.
10.9 biolitec AG
10.10 Biotec Italia Srl
10.11 Brera Medical Technologies Srl
10.12 Candela Corporation
10.13 Cartessa Aesthetics, LLC
10.14 Celling Biosciences, LLC. (ThermiGen)
10.15 Cutera Inc.
10.16 Cynosure, LLC
10.17 Dominion Aesthetic Technologies, Inc.
10.18 El. En. S.p.A.
10.19 Endymed Ltd.
10.20 Erchonia Corporation
10.21 Galderma S.A.
10.22 Inmode Ltd
10.23 Johnson & Johnson
10.24 Linline Medical Systems, SIA
10.25 Lumenis Inc.
10.26 Lutronic, Inc.
10.27 Lynton Lasers Ltd
10.28 MedArt ApS
10.29 Medytox Inc.
10.30 Merz Pharma GmbH & Co. KGaA
10.31 Meyer-Haake GmbH
10.32 Microaire Surgical Instruments LLC
10.33 Revance Therapeutics, Inc.
10.34 Sciton, Inc.
10.35 Sientra, Inc.
10.36 Sisram Medical Ltd.
10.37 Venus Concept Inc.
10.38 WAVEMED SRL
10.39 Wuhan Gigaa Optronics Technology Co., Ltd.
10.40 Zimmer MedizinSysteme GmbH
DISCLAIMER
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL MEDICAL AESTHETICS MARKET BY PROCEDURE
5.1 Minimally invasive procedure
5.2 Non-invasive procedure
PART 6. GLOBAL MEDICAL AESTHETICS MARKET BY PRODUCT
6.1 Body contouring devices
6.2 Cosmetic implants
6.3 Filler and neuromodulators
6.4 Laser and energy-based devices
6.5 Microdermabrasion (MDA)
6.6 Microneedling and chemical peels
6.7 Others
PART 7. GLOBAL MEDICAL AESTHETICS MARKET BY APPLICATION
7.1 Body contouring and cellulite reduction
7.2 Breast augmentation
7.3 Facial aesthetics
7.4 Skin tightening and brightening
7.5 Others
PART 8. GLOBAL MEDICAL AESTHETICS MARKET BY END USER
8.1 Homecare
8.2 Hospital and skin clinics
8.3 Medical spa
PART 9. GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY
9.1 North America
9.2 Europe
9.3 APAC
9.4 Latin America
9.5 Middle East & Africa
PART 10. COMPANY PROFILES
10.1 Abbvie Inc. (Allergan plc)
10.2 Aerolase Corporation
10.3 Aesthetics Biomedical, Inc.
10.4 Asclepion Laser Technologies GmbH
10.5 Astanza Laser LLC
10.6 Bausch & Lomb Incorporated
10.7 Bausch Health Companies Inc.
10.8 Beijing Sanhe Beauty S & T Co., Ltd.
10.9 biolitec AG
10.10 Biotec Italia Srl
10.11 Brera Medical Technologies Srl
10.12 Candela Corporation
10.13 Cartessa Aesthetics, LLC
10.14 Celling Biosciences, LLC. (ThermiGen)
10.15 Cutera Inc.
10.16 Cynosure, LLC
10.17 Dominion Aesthetic Technologies, Inc.
10.18 El. En. S.p.A.
10.19 Endymed Ltd.
10.20 Erchonia Corporation
10.21 Galderma S.A.
10.22 Inmode Ltd
10.23 Johnson & Johnson
10.24 Linline Medical Systems, SIA
10.25 Lumenis Inc.
10.26 Lutronic, Inc.
10.27 Lynton Lasers Ltd
10.28 MedArt ApS
10.29 Medytox Inc.
10.30 Merz Pharma GmbH & Co. KGaA
10.31 Meyer-Haake GmbH
10.32 Microaire Surgical Instruments LLC
10.33 Revance Therapeutics, Inc.
10.34 Sciton, Inc.
10.35 Sientra, Inc.
10.36 Sisram Medical Ltd.
10.37 Venus Concept Inc.
10.38 WAVEMED SRL
10.39 Wuhan Gigaa Optronics Technology Co., Ltd.
10.40 Zimmer MedizinSysteme GmbH
DISCLAIMER
RELATED REPORTS
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
View ReportGlobal Medical Injection Molded Plastics Market 2023
Medical injection molded plastics are used in the manufacturing of various medical devices and components, such as syringes, vials, IV components, and other disposable medical products. These plastics are designed
View ReportGlobal Medical Device Coatings Market 2023
The global medical device coatings market is projected to reach USD 15.58 billion by 2029, with a CAGR of 4.8% from 2023 to 2029. Market growth is driven by the
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
